Vera Therapeutics, Inc.(VERA)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Fordyce Marshall PRESIDENT AND CEO | Sale | -18,500 | -7.86%216,744 | $36.74 | $679,747 | View SEC filing | |
| 2026-04-15 | Fordyce Marshall PRESIDENT AND CEO | Sale | -22,951 | -8.89%235,244 | $44.05 | $1,011,051 | View SEC filing | |
| 2026-02-25 | Skelton Laurence Matthew Chief Commercial Officer | Sale | -1,582 | -2.40%64,218 | $41.98 | $66,419 | View SEC filing | |
| 2026-02-25 | Brenner Robert Chief Medical Officer | Sale | -2,151 | -4.05%50,947 | $41.98 | $90,307 | View SEC filing | |
| 2026-02-25 | Grant Sean CHIEF FINANCIAL OFFICER | Sale | -4,949 | -4.15%114,181 | $41.98 | $207,778 | View SEC filing | |
| 2026-02-25 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | -3,117 | -4.59%64,722 | $41.98 | $130,864 | View SEC filing | |
| 2026-02-25 | Fordyce Marshall PRESIDENT AND CEO | Sale | -16,925 | -6.18%257,163 | $41.98 | $710,578 | View SEC filing | |
| 2026-02-25 | Turner William D. Chief Regulatory Officer | Sale | -2,187 | -4.60%45,313 | $41.98 | $91,819 | View SEC filing | |
| 2026-02-25 | JOHNSON DAVID LEE Chief Operating Officer | Sale | -2,579 | -5.34%45,727 | $41.98 | $108,276 | View SEC filing | |
| 2025-12-17 | Turner William D. Chief Regulatory Officer | Sale | -10,000 | -30.77%22,500 | $50.08 | $500,767 | View SEC filing | |
| 2025-12-15 | ENRIGHT PATRICK G Director | Purchase | +5,882 | +100.00%5,882 | $42.50 | $249,985 | View SEC filing | |
| 2025-12-10 | Turner William D. Chief Regulatory Officer | Sale | -10,000 | -30.77%22,500 | $45.31 | $453,053 | View SEC filing | |
| 2025-12-04 | Turner William D. Chief Regulatory Officer | Sale | -10,000 | -30.77%22,500 | $40.00 | $400,000 | View SEC filing | |
| 2025-11-25 | Carter Jason S Chief Legal Officer | Sale | -3,864 | -7.29%49,136 | $27.82 | $107,498 | View SEC filing | |
| 2025-11-13 | Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | Sale | -15,000 | -23.87%47,839 | $29.06 | $435,875 | View SEC filing | |
| 2025-06-25 | ENRIGHT PATRICK G Director | Purchase | +250,000 | +109.80%3,596,593 | $21.11 | $5,277,311 | View SEC filing | |
| 2025-02-27 | Fordyce Marshall PRESIDENT AND CEO | Sale | -19,688 | -8.78%204,665 | $27.78 | $546,914 | View SEC filing | |
| 2025-01-10 | Fordyce Marshall PRESIDENT AND CEO | Sale | -17,500 | -6.50%143,603 | $41.74 | $730,535 | View SEC filing | |
| 2024-12-20 | Fordyce Marshall PRESIDENT AND CEO | Sale | -17,500 | -4.20%85,942 | $43.07 | $753,680 | View SEC filing | |
| 2024-12-13 | Fordyce Marshall PRESIDENT AND CEO | Sale | -17,500 | -14.80%85,942 | $46.94 | $821,523 | View SEC filing | |
| 2024-11-27 | Fordyce Marshall PRESIDENT AND CEO | Sale | -19,375 | -7.11%85,942 | $47.98 | $929,560 | View SEC filing | |
| 2024-11-15 | Fordyce Marshall PRESIDENT AND CEO | Sale | -30,625 | -12.45%85,942 | $49.50 | $1,516,037 | View SEC filing | |
| 2024-10-30 | SEIDENBERG BETH C Director | Sale | -15,000 | -10.24%131,553 | $48.03 | $720,493 | View SEC filing | |
| 2024-10-25 | Fordyce Marshall PRESIDENT AND CEO | Sale | -19,375 | -3.96%307,972 | $40.39 | $782,610 | View SEC filing | |
| 2024-10-11 | Fordyce Marshall PRESIDENT AND CEO | Sale | -15,625 | -3.83%307,972 | $38.24 | $597,568 | View SEC filing |
1-25 of 95